TAXANES IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER

TAXANES IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER

Currently, the study of mechanisms of development and introduction of the most effective treatment for castration-resistant prostate cancer (CRPC) – one of the most highlighted problems concerning facing oncologists and urologists worldwide. Several large randomized trials recently (TAX 327 , SWOG 9...

Full description

Bibliographic Details
Main Authors: T. N. Skvortsova, S. V. Mishugin, A. A. Gritskevich, I. G. Rusakov
Format: Article
Language:English
Published: Bashkir State Medical University 2017-01-01
Series:Креативная хирургия и онкология
Subjects:
castration-resistant cancer
prostate
docetaxel
cabazitaxel
taxanes
Online Access:https://www.surgonco.ru/jour/article/view/12

Internet

https://www.surgonco.ru/jour/article/view/12

Similar Items